Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

ANIPRDY

ANI Pharmaceuticals, Inc.

ANIP · $72.61

76Strong

Dr. Reddy's Laboratories Limited

RDY · $13.21

55Fair

Area by area

Overall Quant Score

How does it look overall? (out of 100)

ANIP

76/100

RDY

55/100

Quality

Is it a profitable, well-run business?

ANIP

4.9/10

RDY

1.8/10

Growth

Is the company growing?

ANIP

9.5/10

RDY

2.7/10

Valuation

Is the price reasonable? (higher = cheaper)

ANIP

9.9/10

RDY

4.9/10

Risk

How risky are the shares? (higher = lower risk)

ANIP

8.1/10

RDY

7.8/10

Momentum

Is the share price trending up?

ANIP

6.0/10

RDY

7.4/10

Financial strength

Is the balance sheet healthy?

ANIP

6.0/10

RDY

6.6/10

The balanced view

Model-generated

ANI Pharmaceuticals, Inc.

This company scores well across most areas, with a reasonable valuation and solid growth.

Leads on: quality, growth, valuation, risk

Best feature: reasonable valuation (PEG: 0.01)

Watch out: weakest area: business quality (Return on invested capital (TTM): 9.3%)

Dr. Reddy's Laboratories Limited

This company has a mixed profile, with a relatively low-risk profile and a positive price trend, although its profitability is thin.

Leads on: momentum, financial strength

Best feature: relatively low risk (Beta (vs. market): 0.25)

Watch out: profitability is thin (Return on invested capital (TTM): 5.8%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.